Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs CHD✓SelectedUSD · CHDGSK vs CHD performance historyLatest closeAs of-2.32%11/17
Stock and ETF performance explorer

GSK vs CHD

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+103.1%
CHD return
+187.2%
Excess return
-84.2%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioCHDExcessAlpha
1D-2.3%-2.0%-0.4%-1.7%
7D-3.0%+0.9%-3.9%-3.3%
30D+0.4%+7.9%-7.6%-2.0%
3M-1.2%+15.1%-16.3%-5.4%
6M+0.9%+20.3%-19.4%-4.8%
YTD+4.0%+35.8%-31.8%-5.3%
1Y+7.3%+37.1%-29.8%-2.7%
3Y+57.1%+26.2%+30.9%+45.4%
5Y+43.0%+30.5%+12.5%+29.1%
10Y+103.1%+187.7%-84.7%+54.1%
All+103.1%+187.2%-84.2%+54.1%

Cumulative growth

Daily Returns

Daily percentage return beside CHD.

Daily Out/Under-Performance

Portfolio return minus CHD return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CHD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded CHD wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling